CD226+ B cells also presented enhanced pro-inflammatory cytokine production like TNF-α, IFN-γ, IL-6, and IL-12 than those in CD226− B cells from T1D (Fig. 2d) and LADA patients (Supplementary Fig. S2e). The gene discussed is CD226; the disease is type 1 diabetes mellitus.